Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience

Varghese, J; Kedarisetty, CK; Venkataraman, J; Srinivasan, V; Deepashree, T; Uthappa, MC; Ilankumaran, K; Govil, S; Reddy, MS; Rela, M

Venkataraman, J (reprint author), Inst Liver Dis & Transplantat, Global Hlth city,Perumbakkam, Chennai 600100, Tamil Nadu, India.

ANNALS OF HEPATOLOGY, 2017; 16 (2): 247

Abstract

Background & Aim. Transarterial chemoembolization (TACE) or sorafenib is recommended for hepatocellular carcinoma BCLC stages B and C respectively......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索